plerixafor has been researched along with Ovarian Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 10 (76.92) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Gao, D; Li, R; Xie, H; Xue, J | 1 |
| Fan, KF; Liu, CL; Mao, TL | 1 |
| Abbaslou, MA; Kools, FRW; Poznansky, MC; Reeves, PM | 1 |
| Chen, YN; Liu, Y; Ren, CC; Xu, YM; Yang, L | 1 |
| Chen, J; Gao, Y; Jia, L; Li, B; Liu, J; Liu, W; Shao, J; Wang, J; Zheng, N | 1 |
| Callahan, MV; Chen, H; Gelfand, JA; Li, B; Liang, Y; Liu, Q; Poznansky, MC; Qu, X; Ran, C; Reeves, PM; Sluder, AE; Zeng, Y | 1 |
| Ge, J; Huang, K; Qi, C; Wu, W; Xie, T; Xu, X; Xue, B; Yu, Y; Zhang, H | 1 |
| Chen, X; Farber, JM; Jacobson, O; Jacobus, JP; Kiesewetter, DO; Szajek, LP; Weiss, ID | 1 |
| Kajiyama, H; Kikkawa, F; Mitsui, H; Mizuno, M; Shibata, K; Suzuki, S; Umezu, T | 1 |
| Lewin, SA; Luker, GD; Luker, KE; Mihalko, LA; Ray, P; Schmidt, BT | 1 |
| Ehrlich, A; Luker, GD; Luker, KE; Salomonnson, E; Stacer, AC | 1 |
| Balkwill, FR; Bridger, G; Fricker, S; Scott, K; Scotton, CJ; Stamp, G; Wilbanks, GD; Wilson, JL | 1 |
| Ino, K; Kajiyama, H; Kikkawa, F; Nawa, A; Shibata, K; Terauchi, M | 1 |
13 other study(ies) available for plerixafor and Ovarian Neoplasms
| Article | Year |
|---|---|
CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Cell Line, Tumor; Chemokine CXCL12; CHO Cells; Cricetulus; Cyclams; Drug Delivery Systems; Female; Heterocyclic Compounds; Humans; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Multifunctional Nanoparticles; Ovarian Neoplasms; Paclitaxel; Receptors, CXCR4; Serum Albumin, Bovine; Xenograft Model Antitumor Assays | 2020 |
Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer.
Topics: Animals; Benzylamines; Carcinoma; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Female; Heterocyclic Compounds; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Ovarian Neoplasms; rac1 GTP-Binding Protein; Receptors, CXCR4; rhoA GTP-Binding Protein; RNAi Therapeutics | 2017 |
CXCR4 blockade with AMD3100 enhances Taxol chemotherapy to limit ovarian cancer cell growth.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Cell Growth Processes; Cell Line, Tumor; Cyclams; Dose-Response Relationship, Drug; Drug Synergism; Female; Heterocyclic Compounds; Humans; Mice; Ovarian Neoplasms; Paclitaxel; Receptors, CXCR4 | 2017 |
Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro.
Topics: Adult; Aged; Antineoplastic Agents; Apoptosis; Benzylamines; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CXCL12; Cyclams; Female; Heterocyclic Compounds; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Ovarian Neoplasms; Receptors, CXCR4; Signal Transduction | 2019 |
CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer.
Topics: Animals; Apoptosis; Benzylamines; Biomarkers, Tumor; Cell Movement; Cell Proliferation; Chemokine CXCL12; Cyclams; Epithelial-Mesenchymal Transition; Female; Heterocyclic Compounds; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Ovarian Neoplasms; Peritoneal Neoplasms; Receptors, CXCR; Receptors, CXCR4; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment.
Topics: Animals; B7-H1 Antigen; Benzylamines; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Female; Heterocyclic Compounds; Immune Tolerance; Mice; Neoplasm Proteins; Ovarian Neoplasms; Programmed Cell Death 1 Receptor; Receptors, CXCR4; Signal Transduction; Tumor Microenvironment | 2019 |
Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer.
Topics: Antigens, Neoplasm; Benzylamines; Blotting, Western; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Chromones; Cyclams; Dose-Response Relationship, Drug; Extracellular Matrix; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Imidazoles; Integrins; Morpholines; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Time Factors; Urokinase-Type Plasminogen Activator | 2013 |
Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of 64Cu-AMD3100.
Topics: Animals; Benzylamines; Carcinoma, Lewis Lung; Cell Line, Tumor; CHO Cells; Copper Radioisotopes; Cricetinae; Cricetulus; Cyclams; Female; Heterocyclic Compounds; Humans; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Molecular Imaging; Neoplasms, Experimental; Ovarian Neoplasms; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Receptors, CXCR4; Tissue Distribution; Transfection; Transplantation, Heterologous | 2012 |
Functional interaction between peritoneal mesothelial cells and stem cells of ovarian yolk sac tumor (SC-OYST) in peritoneal dissemination.
Topics: AC133 Antigen; Animals; Antigens, CD; Benzylamines; Cell Communication; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Coculture Techniques; Cyclams; Endodermal Sinus Tumor; Epithelium; Female; Glycoproteins; Heterocyclic Compounds; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplastic Stem Cells; Ovarian Neoplasms; Peptides; Peritoneal Cavity; Receptors, CXCR4 | 2012 |
Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4.
Topics: Animals; Antineoplastic Agents; Benzylamines; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Female; Genes, Reporter; Heterocyclic Compounds; Humans; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Molecular Imaging; Molecular Targeted Therapy; Ovarian Neoplasms; Protein Binding; Receptors, CXCR4; Recombinant Fusion Proteins; Signal Transduction | 2011 |
Imaging CXCL12-CXCR4 signaling in ovarian cancer therapy.
Topics: Animals; Antineoplastic Agents; Arrestins; Benzylamines; beta-Arrestin 2; beta-Arrestins; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL12; Cisplatin; Cyclams; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Heterocyclic Compounds; Humans; Luciferases; Luminescent Measurements; Mice; Mice, SCID; Molecular Imaging; Neoplasm Transplantation; Ovarian Neoplasms; Receptors, CXCR4; Signal Transduction | 2013 |
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.
Topics: Benzylamines; Cell Division; Chemokine CXCL12; Chemokines, CXC; Cyclams; Enzyme Activation; Female; Heterocyclic Compounds; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Ovarian Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, CXCR4; Tumor Necrosis Factor-alpha | 2002 |
Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Animals; Anti-HIV Agents; Benzylamines; Blotting, Western; Carcinoma, Endometrioid; Cell Adhesion; Cell Movement; Chemokine CXCL12; Coculture Techniques; Cyclams; Cystadenocarcinoma, Serous; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Heterocyclic Compounds; Humans; Immunoenzyme Techniques; Mice; Middle Aged; Mitogen-Activated Protein Kinases; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Peritoneum; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, CXCR4; Signal Transduction | 2008 |